Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-19 | Ms. Parker received her B.A. and M.B.A. from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development stage clinical development, public company expertise, and business development for pharmaceuticals and biologics. |
| 2011-04-21 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development-stage clinical development, public company expertise, and business development for pharmaceuticals and biologics. |
| 2012-04-26 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. |
| 2013-04-22 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development-stage clinical development, public company expertise, and business development experience for pharmaceuticals and biologics. |
| 2014-04-24 | Stewart Parker, 58, has served as a director since March 2010. Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. |
| 2015-04-16 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development-stage clinical development, public company expertise, and business development experience for pharmaceuticals and biologics. |
| 2017-09-21 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development-stage clinical development, public company expertise, and business development experience for pharmaceuticals and biologics. |
| 2018-04-19 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. |
| 2018-08-16 | Stewart Parker Represents 117 shares owned directly and 1,512 options exercisable within 60 days of July 30, 2018. |
| 2019-03-28 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. |
| 2020-04-02 | Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms. Parker should serve on our Board of Directors due to her executive leadership experience in development-stage clinical development, public company expertise, and business development experience for pharmaceuticals and biologics. |
Data sourced from SEC filings. Last updated: 2025-10-11